Vihang A. Narkar

Dr. Vihang A. Narkar

Uthealth Mcgovern Medical School, Institute of Molecular Medicine, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in Science
Verified
Journal Article
Closed access
PDF file
NKNelson H. Knudsen
Nelson H. Knudsen
KSKristopher J. Stanya
Kristopher J. Stanya
AHAlexander L. Hyde
Alexander L. Hyde
MCMayer M. Chalom
Mayer M. Chalom
RARyan K. Alexander
Ryan K. Alexander
CLChih-Hao Lee
Chih-Hao Lee
IL-13 hits the gym: Interleukin-13 (IL-13) is a cytokine secreted by T cells, innate lymphoid cells (ILC2s), and granulocytes. It acts as a central mediator in allergy and antihelminth defense with various effects. Knudsen et al. report a distinct role for IL-13 in exercise and metabolism (see the Perspective by Correia and Ruas). Mice subjected to endurance training showed increases in circulating IL-13, which correlated with ILC2 expansion in the muscles. By contrast, exercise-induced increases in muscle fatty acid utilization and mitochondrial biogenesis were erased when mice lacked IL-13. Activation of signaling pathways downstream of the muscle IL-13 receptor was key to this effect. Intramuscular injection of adenoviral IL-13 could recapitulate exercise-induced metabolic reprogramming. This signaling pathway may have evolved to combat the metabolic stresses of parasite infection. Science , this issue p. eaat3987 ; see also p. 470

18 June 2013 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
Antonios MatsakasAntonios Matsakas
Antonios Matsakas
VYVikas Yadav
Vikas Yadav
SLSabina Lorca
Sabina Lorca
Vihang A. NarkarVihang A. Narkar
Vihang A. Narkar
Treatment of Duchenne muscular dystrophy (DMD) by replacing mutant dystrophin or restoring dystrophin‐associated glycoprotein complex (DAG) has been clinically challenging. Instead, identifying and targeting muscle pathways deregulated in DMD will provide new therapeutic avenues. We report that the expression of nuclear receptor estrogen‐related receptor‐γ (ERRγ), and its metabolic and angiogenic targets are downregulated (50–85%) in skeletal muscles of mdx mice (DMD model) vs. wild‐type mice. Corelatively, oxidative myofibers, muscle vasculature, and exercise tolerance (33%) are decreased in mdx vs. wild‐type mice. Overexpressing ERRγ selectively in the dystrophic muscles of the mdx mice restored metabolic and angiogenic gene expression compared with control mdx mice. Further, ERRγ enhanced muscle oxidative myofibers, vasculature, and blood flow (by 33–66%) and improved exercise tolerance (by 75%) in the dystrophic mice. Restoring muscle ERRγ pathway ameliorated muscle damage and also prevented DMD hallmarks of postexercise muscle damage, hypoxia, and fatigue in mdx mice. Notably, ERRγ did not restore sarcolemmal DAG complex, which is thus dispensable for antidystrophic effects of ERRγ. In summary, ERRγ‐dependent metabolic and angiogenic gene program is defective in DMD, and we demonstrate that its restoration is a potential strategy for treating muscular dystrophy.—Matsakas, A., Yadav, V., Lorca, S., Narkar, V., Muscle ERRγ mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming. FASEB J. 27, 4004–4016 (2013). www.fasebj.org

13 April 2012 in Circulation Research
Verified
Journal Article
Closed access
PDF file
Antonios MatsakasAntonios Matsakas
Antonios Matsakas
VYVikas Yadav
Vikas Yadav
SLSabina Lorca
Sabina Lorca
RERonald M. Evans
Ronald M. Evans
Vihang A. NarkarVihang A. Narkar
Vihang A. Narkar
Rationale:: Oxidative myofibers in the skeletal muscles express high levels of angiogenic factors, have dense vasculature, and promptly revascularize during ischemia. Estrogen-related receptor-gamma (ERRγ) activates genes that govern metabolic and vascular features typical to oxidative myofibers. Therefore, ERRγ-dependent remodeling of the myofibers may promote neoangiogenesis and restoration of blood perfusion in skeletal muscle ischemia. Objective:: To investigate the muscle fiber type remodeling by ERRγ and its role in the vascular recovery of ischemic muscle. Methods and Results:: Using immunohistology, we show that skeletal muscle-specific transgenic overexpression of ERRγ increases the proportions of oxidative and densely vascularized type IIA and IIX myofibers and decreases glycolytic and less vascularized type IIB myofibers. This myofiber remodeling results in a higher basal blood flow in the transgenic skeletal muscle. By applying unilateral hind limb ischemia to transgenic and wild-type mice, we found accelerated revascularization (fluorescent microangiography), restoration of blood perfusion (laser Doppler flowmetry), and muscle repair (Evans blue dye exclusion) in transgenic compared to wild-type ischemic muscles. This ameliorative effect is linked to enhanced neoangiogenesis (CD31 staining and microfil perfusion) by ERRγ. Using cultured muscle cells in which ERRγ is inactivated, we show that the receptor is dispensable for the classical hypoxic response of transcriptional upregulation and secretion of vascular endothelial growth factor A. Rather, the ameliorative effect of ERRγ is linked to the receptor-mediated increase in oxidative myofibers that inherently express and secrete high levels of angiogenic factors. Conclusions:: The ERRγ is a hypoxia-independent inducer of neoangiogenesis that can promote reparative revascularization.

31 March 2021 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
DSDanesh H. Sopariwala
Danesh H. Sopariwala
NLNeah Likhite
Neah Likhite
GPGungsheng Pei
Gungsheng Pei
FHFnu Haroon
Fnu Haroon
LLLisa Lin
Lisa Lin
Vihang A. NarkarVihang A. Narkar
Vihang A. Narkar

30 December 2022 in The FASEB Journal
Verified
Journal Article
Open access
DSDanesh H. Sopariwala
Danesh H. Sopariwala
ARAndrea S. Rios
Andrea S. Rios
GPGuangsheng Pei
Guangsheng Pei
ARAnirban Roy
Anirban Roy
MSMeiricris Tomaz da Silva
Meiricris Tomaz da Silva
Vihang A. NarkarVihang A. Narkar
Vihang A. Narkar
Transcriptional determinants in the skeletal muscle that govern exercise capacity, while poorly defined, could provide molecular insights into how exercise improves fitness. Here, we have elucidated the role of nuclear receptors, estrogen‐related receptor alpha and gamma (ERRα/γ) in regulating myofibrillar composition, contractility, and exercise capacity in skeletal muscle. We used muscle‐specific single or double (DKO) ERRα/γ knockout mice to investigate the effect of ERRα/γ deletion on muscle and exercise parameters. Individual knockout of ERRα/γ did not have a significant impact on the skeletal muscle. On the other hand, DKO mice exhibit pale muscles compared to wild‐type (WT) littermates. RNA‐seq analysis revealed a predominant decrease in expression of genes linked to mitochondrial and oxidative metabolism in DKO versus WT muscles. DKO muscles exhibit marked repression of oxidative enzymatic capacity, as well as mitochondrial number and size compared to WT muscles. Mitochondrial function is also impaired in single myofibers isolated from DKO versus WT muscles. In addition, mutant muscles exhibit reduced angiogenic gene expression and decreased capillarity. Consequently, DKO mice have a significantly reduced exercise capacity, further reflected in poor fatigue resistance of DKO mice in in vivo contraction assays. These results show that ERRα and ERRγ together are a critical link between muscle aerobic capacity and exercise tolerance. The ERRα/γ mutant mice could be valuable for understanding the long‐term impact of impaired mitochondria and vascular supply on the pathogenesis of muscle‐linked disorders.

1 March 2019 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
NLNeah Likhite
Neah Likhite
VYVikas Yadav
Vikas Yadav
EMEric J. Milliman
Eric J. Milliman
DSDanesh H. Sopariwala
Danesh H. Sopariwala
SLSabina Lorca
Sabina Lorca
Vihang A. NarkarVihang A. Narkar
Vihang A. Narkar
Estrogen-related receptors (ERRs) have emerged as major metabolic regulators in various tissues. However, their expression and function in the vasculature remains unknown. Here we report the transcriptional program and cellular function of ERRα in endothelial cells (ECs), a cell type with a multi-faceted role in vasculature. Of the three ERR subtypes ECs exclusively express ERRα. Gene expression profiling of ECs lacking ERRα revealed that ERRα predominantly acts as a transcriptional repressor, targeting genes linked with angiogenesis, cell migration and cell adhesion. ERRα-deficient ECs exhibit decreased proliferation, but increased migration and tube formation. ERRα depletion increased basal, VEGFA and ANG1/2 stimulated angiogenic sprouting in endothelial spheroids. Moreover, retinal angiogenesis is enhanced in ERRα knockout mice compared to wild type mice. Surprisingly, ERRα is dispensable for the regulation of its classic targets such as metabolism, mitochondrial biogenesis and cellular respiration in the ECs. ERRα is enriched at the promoters of angiogenic, migratory and cell adhesion genes. Further, VEGFA increased ERRα recruitment to angiogenesis-associated genes and simultaneously decreased their expression. Despite increasing its gene occupancy, pro-angiogenic stimuli decrease ERRα expression in ECs. Our work shows that endothelial ERRα plays a repressive role in angiogenesis, and potentially fine-tunes growth factor-mediated angiogenesis. IMPORTANCE Impaired angiogenesis, the process of blood vessel formation, is central to various diseases including peripheral vascular disease, retinopathy, nephropathy, cardiac ischemia and cancer. While few angiogenic regulators have been described, full breadth of the cellular and molecular pathways that regulate this phenomenon are far from clear. Fundamental discoveries related to angiogenesis regulation could lead to new drugs that normalize blood vessels in the aforementioned diseases. Using a cell and molecular biology approach, our work highlights a gene regulator called ERRα in endothelial cells (the building blocks of the vasculature), which plays a role in limiting angiogenic activation by controlling endothelial gene expression. It can be envisioned that future pre-clinical and pharmaco/physiological studies could lead to advancement of ERRα as a therapeutic regulator of angiogenesis in vascular-linked diseases.